CID 49836058

Evacetrapib

Structural Information

Molecular Formula
C31H36F6N6O2
SMILES
CC1=CC(=C2C(=C1)[C@H](CCCN2CC3CCC(CC3)C(=O)O)N(CC4=CC(=CC(=C4)C(F)(F)F)C(F)(F)F)C5=NN(N=N5)C)C
InChI
InChI=1S/C31H36F6N6O2/c1-18-11-19(2)27-25(12-18)26(5-4-10-42(27)16-20-6-8-22(9-7-20)28(44)45)43(29-38-40-41(3)39-29)17-21-13-23(30(32,33)34)15-24(14-21)31(35,36)37/h11-15,20,22,26H,4-10,16-17H2,1-3H3,(H,44,45)/t20?,22?,26-/m0/s1
InChIKey
IHIUGIVXARLYHP-UXNJHFGPSA-N
Compound name
4-[[(5S)-5-[[3,5-bis(trifluoromethyl)phenyl]methyl-(2-methyltetrazol-5-yl)amino]-7,9-dimethyl-2,3,4,5-tetrahydro-1-benzazepin-1-yl]methyl]cyclohexane-1-carboxylic acid
Related CIDs

2D Structure

compound 2d structure
6
Annotation Hits

78
References

1086
Patents

638.2804 Da
Monoisotopic Mass

7.7
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 639.28768 246.0
[M+Na]+ 661.26962 250.5
[M-H]- 637.27312 247.1
[M+NH4]+ 656.31422 243.1
[M+K]+ 677.24356 247.1
[M+H-H2O]+ 621.27766 227.8
[M+HCOO]- 683.27860 244.7
[M+CH3COO]- 697.29425 266.9
[M+Na-2H]- 659.25507 238.4
[M]+ 638.27985 235.0
[M]- 638.28095 235.0
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

patents stripe